Both pediatric and adult. Our current mission is to provide solutions to cancer patients, both pediatric and adult. Our future plan is to also provide solutions to patients suffering from infections, or who need advanced therapies for the regeneration of marrow, cartilage,the spinal cord, etc.

We address an unmet oncological and surgical need, and we do it through our first drug, CEB-01, which helps surgeons in their oncological operations.

Our aim is for CEB-01 to be included in the ‘Standard of Care’ for oncological surgery.